Convicted pharma exec’s name stripped from U of Buffalo pharmacy school

Insys Therapeutics founder John Kapoor’s name will be removed from the University of Buffalo (N.Y.) School of Pharmacy, following Kapoor’s conviction last month in a racketeering conspiracy, according to Buffalo News.

Advertisement

Mr. Kapoor was found guilty in a Boston court of bribing physicians to overprescribe Insys’ opioid-based drug Subsys to boost profits. Prosecutors accused Mr. Kapoor of orchestrating a nationwide bribery scheme.

The pharmacy building was named John and Editha Kapoor Hall in honor of the couple who donated $10.8 million to the university. Mr. Kapoor graduated from the University of Buffalo with a doctorate in medicinal chemistry in 1972.

The University at Buffalo Council council voted to take Kapoor’s name off the building June 3.

More articles on pharmacy:
Viewpoint: The $2.1M drug price record won’t last long
Mallinckrodt to spin off generics unit
Pharma exec Martin Shkreli sues Retrophin directors from prison

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

  • The Health Resources and Services Administration has revised its 340B Rebate Model Pilot Program, establishing a voluntary pathway for qualifying…

  • Polypharmacy was the only higher-risk medication exposure independently associated with increased all-cause mortality among older adults after accounting for drug-drug…

Advertisement

Comments are closed.